Universities' drug discoveries must aid poor countries, student group saysBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39041.374086.DB (Published 23 November 2006) Cite this as: BMJ 2006;333:1090
- Janice Hopkins Tanne
- 1New York
Universities should change the way they license research developments so as to make new drugs, vaccines, and diagnostic tests available to people in poor countries, says Universities Allied for Essential Medicines, a coalition of students at universities across North America.
The group's “Philadelphia consensus” says that universities should promote equal access to the results of their research, conduct research on neglected diseases, and measure their research success by its effect on human welfare.
“Universities are key developers of drugs, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial